Online Database of Chemicals from Around the World

3-Methyl-6-nitroindazole
[CAS# 6494-19-5]

List of Suppliers
Capot Chemical Co., Ltd. China Inquire
www.capotchem.com
+86 (571) 8558-6718
+86 13336195806
+86 (571) 8586-4795
capotchem@gmail.com
sales@capotchem.com
QQ Chat
Chemical manufacturer
chemBlink Standard supplier since 2006
Simagchem Corporation China Inquire
www.simagchem.com
+86 13806087780
+86 (592) 268-0237
sale@simagchem.com
Chemical manufacturer since 2002
chemBlink Standard supplier since 2008
BOC Sciences USA Inquire
www.bocsci.com
+1 (631) 485-4226
+1 (631) 614-7828
info@bocsci.com
Chemical manufacturer
chemBlink Standard supplier since 2010
Shanghai Famo Bio-chemical Technology Company Ltd. China Inquire
www.famobiotech.com
+86 (21) 6816-0314
+86 (21) 5816-6562
sales@famobiotech.com
pharmabiotech@hotmail.com
QQ Chat
Chemical manufacturer
chemBlink Standard supplier since 2011
Hangzhou Leap Chem Co., Ltd. China Inquire
www.leapchem.com
+86 (571) 8771-1850
market19@leapchem.com
QQ Chat
Chemical manufacturer since 2006
chemBlink Standard supplier since 2015
Amadis Chemical Co., Ltd. China Inquire
www.amadischem.com
+86 (571) 8992-5085
+86 (571) 8992-5065
sales@amadischem.com
Chemical manufacturer since 2010
chemBlink Standard supplier since 2015
Neostar United (Changzhou) Industrial Co., Ltd. China Inquire
www.neostarunited.com
+86 (519) 8555-7386
+86 18015025600
+86 (519) 8555-7389
marketing1@neostarunited.com
Chemical distributor since 2014
chemBlink Standard supplier since 2020
Nanjing Hike Biological Technology Co., Ltd. China Inquire
www.njhkchem.com
+86 (25) 5211-0956
+86 (25) 5211-0956
sophia@njhkchem.com
QQ Chat
Skype Chat
WeChat: 17372769668
WhatsApp:17372769668
Chemical distributor since 2021
chemBlink Standard supplier since 2024
Spectrum Info Ltd. Ukraine Inquire
www.spec-info.com
+38 (044) 573-5462
+38 (044) 573-2397
spec-info@spec-info.com
Chemical manufacturer

Identification
ClassificationOrganic raw materials >> Heterocyclic compound >> Indazoles
Name3-Methyl-6-nitroindazole
Synonyms3-Methyl-6-nitro-1H-indazole
Molecular StructureCAS # 6494-19-5, 3-Methyl-6-nitroindazole
Molecular FormulaC8H7N3O2
Molecular Weight177.16
CAS Registry Number6494-19-5
EC Number613-731-0
SMILESCC1=C2C=CC(=CC2=NN1)[N+](=O)[O-]
Properties
Density1.437±0.1 g/cm3, Calc.*
Melting point184-188 °C (Expl.)
Index of Refraction1.707, Calc.*
Boiling Point384.9±22.0 °C (760 mmHg), Calc.*
Flash Point186.6±22.3 °C, Calc.*
*Calculated using Advanced Chemistry Development (ACD/Labs) Software.
Safety Data
Hazard Symbolssymbol   GHS07 Warning  Details
Risk StatementsH302+H312+H332-H302-H312-H315-H319-H332-H335  Details
Safety StatementsP203-P261-P264-P264+P265-P270-P271-P273-P280-P301+P317-P302+P352-P304+P340-P305+P351+P338-P317-P318-P319-P321-P330-P332+P317-P337+P317-P362+P364-P391-P403+P233-P405-P501  Details
Hazard Classification
up    Details
HazardClassCategory CodeHazard Statement
Acute toxicityAcute Tox.4H302
Acute toxicityAcute Tox.4H332
Skin irritationSkin Irrit.2H315
Acute toxicityAcute Tox.4H312
Eye irritationEye Irrit.2H319
Eye irritationEye Irrit.2AH319
Specific target organ toxicity - single exposureSTOT SE3H335
SDSAvailable
up Discovery and Applications
3-Methyl-6-nitroindazole is a heterocyclic organic compound with the molecular formula C8H7N3O2. It belongs to the indazole family, characterized by a bicyclic structure comprising a fused benzene and pyrazole ring. This compound features a methyl group at the third position and a nitro group at the sixth position, conferring unique chemical and biological properties.

The discovery of 3-methyl-6-nitroindazole emerged from research into functionalized indazoles, known for their versatility in medicinal and material sciences. Its synthesis typically involves the nitration of 3-methylindazole using reagents such as nitric acid in the presence of sulfuric acid. This approach ensures selective introduction of the nitro group at the desired position, preserving the structural integrity of the indazole core.

3-Methyl-6-nitroindazole has been extensively explored for its potential in pharmaceutical chemistry. The indazole nucleus is a recurring motif in numerous bioactive compounds, and the addition of methyl and nitro substituents enhances its pharmacological profile. It has been particularly studied as a template for designing inhibitors of nitric oxide synthase (NOS), an enzyme implicated in inflammatory and neurodegenerative diseases. These inhibitors show promise in managing conditions such as ischemia, Alzheimer’s disease, and chronic inflammation.

The compound's nitro group, an electron-withdrawing moiety, influences its reactivity, making it an ideal precursor for synthesizing derivatives with diverse biological activities. It has also been investigated in anticancer research, where modified nitroindazoles demonstrate cytotoxic effects against tumor cells by interfering with cellular pathways.

In addition to pharmaceutical applications, 3-methyl-6-nitroindazole finds use in material sciences. Indazole derivatives are integral to the development of organic light-emitting diodes (OLEDs) and other advanced materials due to their conjugated systems and tunable electronic properties. The nitro functionality allows further chemical modifications, enabling the creation of compounds with specific optical or electronic characteristics.

Furthermore, environmental chemistry leverages 3-methyl-6-nitroindazole in analytical techniques for pollutant detection and neutralization. Its chemical stability and reactivity under controlled conditions make it suitable for designing probes to monitor environmental contaminants.

Continued research into 3-methyl-6-nitroindazole focuses on refining its synthetic pathways, understanding its interaction with biological systems, and expanding its applications in both pharmaceutical and material sciences. Its multifunctional nature highlights the importance of small, functionalized heterocycles in advancing various scientific domains.

References

2022. A patent review on efficient strategies for the total synthesis of pazopanib, regorafenib and lenvatinib as novel anti-angiogenesis receptor tyrosine kinase inhibitors for cancer therapy. Molecular Diversity, 26(5).
DOI: 10.1007/s11030-022-10406-8
Market Analysis Reports
List of Reports Available for 3-Methyl-6-nitroindazole
Related Products
3-Methyl-7-nitr...  4-Methyl-5-Nitr...  4-Methyl-7-nitr...  3-Methyl-6-nitr...  7-Methyl-6-nitr...  1-Methyl-4-Nitr...  2-Methyl-4-Nitr...  3-Methyl-5-nitr...  2-Methyl-5-Nitr...  1-Methyl-7-Nitr...  2-Methyl-6-nitr...  1-Methyl-6-Nitr...  6-Methyl-7-nitr...  5-Methyl-6-nitr...  7-Methyl-5-nitr...  6-Methyl-5-nitr...  6-Methyl-4-nitr...  7-Methyl-4-nitr...  4-Methyl-6-nitr...  Methyl 5-nitro-...